{
    "Trade/Device Name(s)": [
        "VIDAS\u00ae CDAB Assay",
        "VIDAS\u00ae C. difficile Toxin A & B (CDAB) Assay"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K080931",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072138"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LLH"
    ],
    "Summary Letter Date": "June 11, 2008",
    "Summary Letter Received Date": "April 2, 2008",
    "Submission Date": "April 1, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.2660"
    ],
    "Regulation Name(s)": [
        "Microorganism Differentiation and Identification Device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clostridium difficile toxin A",
        "Clostridium difficile toxin B"
    ],
    "Specimen Type(s)": [
        "Stool"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VIDAS instruments"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay",
        "Enzyme-Linked Fluorescent Assay (ELFA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Sandwich assay",
        "Fluorescence detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VIDAS\u00ae CDAB assay, an automated ELFA for qualitative detection of C. difficile toxins A and B in stool specimens",
    "Indications for Use Summary": "Automated test for VIDAS instruments for qualitative detection of C. difficile toxin A and B in stool, aiding in diagnosis of Clostridium difficile associated disease (CDAD)",
    "fda_folder": "Microbiology"
}